Rallybio stock price
랠리바이오NASDAQ:RLYB · Nasdaq · HealthcareToday's signals · Near 52-week high, MA aligned, VCP, MACD bullish cross
Signal details →Rallybio last closed at $17.08 (+1.91%) on 2026-10-02. Signals today: Near 52-week high, MA aligned, VCP, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is 2.2×. Its overall grade ranks 185 of 739 stocks in Healthcare.
About this company
Rallybio last closed at $17.08 (+1.91%) on 2026-10-02. Signals today: Near 52-week high, MA aligned, VCP, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 185/739
Valuation grade D
Related stocks
- RegeneronCompetitor
이식·희귀질환 항체/바이오 치료제 파이프라인에서 경쟁 가능성이 큼
- Alexion PharmaceuticalsCompetitor
희귀질환 치료제 시장의 대표 강자이며 보체계열 타깃에서 경쟁
- Apellis PharmaceuticalsCompetitor
보체(complement) 기반 희귀질환 치료제 개발로 유사한 경쟁 구도
About Rallybio
- What technical signals does Rallybio (RLYB) have?
- Rallybio current technical signals: MA alignment (score 0.55).
- Is Rallybio a cup-and-handle pattern?
- No. Rallybio has no valid Cup signal right now.
- What published figures are available for Rallybio?
- Market cap: $90.16M. Trailing 12 months PER: 2.2×. Latest quarter PBR: 1.05×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Rallybio, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).